Yn dangos 361 i 375 o 940 canlyniadau
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Confidentiality - guidance for registrants
The standards against which we assess education and training programmes